CARDIALLO Trademark

Trademark Overview


On Friday, March 8, 2019, a trademark application was filed for CARDIALLO with the United States Patent and Trademark Office. The USPTO has given the CARDIALLO trademark a serial number of 88332329. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, September 26, 2022. This trademark is owned by BioCardia, Inc.. The CARDIALLO trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the prevention, management, and treatment of connective tissue and ischemic cardiovascular disease and autoimmune diseases and indications; biotechnology preparations in the nature of stems cells derived from a culture of bone marrow cells for use in cell therapy for the prevention, management, diagnosis and treatment of connective tissue and ischemic cardiovascular disease and autoimmune diseases and indications; medical preparations for the prevention, management, and treatment of connective tissue and ischemic cardiovascular disease and autoimmune diseases and indications; human allograft tissue; human tissue for transplantation or implantation, medical and surgical purposes; human cells, including stem cells, and pharmaceutical preparations all used for the treatment, reconstruction and repair of damaged tissue
cardiallo

General Information


Serial Number88332329
Word MarkCARDIALLO
Filing DateFriday, March 8, 2019
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, September 26, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 25, 2019

Trademark Statements


Goods and ServicesPharmaceutical preparations for the prevention, management, and treatment of connective tissue and ischemic cardiovascular disease and autoimmune diseases and indications; biotechnology preparations in the nature of stems cells derived from a culture of bone marrow cells for use in cell therapy for the prevention, management, diagnosis and treatment of connective tissue and ischemic cardiovascular disease and autoimmune diseases and indications; medical preparations for the prevention, management, and treatment of connective tissue and ischemic cardiovascular disease and autoimmune diseases and indications; human allograft tissue; human tissue for transplantation or implantation, medical and surgical purposes; human cells, including stem cells, and pharmaceutical preparations all used for the treatment, reconstruction and repair of damaged tissue

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, March 27, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameBioCardia, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSunnyvale, CA 94085

Party NameBioCardia, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Carlos, CA 94070

Trademark Events


Event DateEvent Description
Monday, September 26, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, September 26, 2022ABANDONMENT - NO USE STATEMENT FILED
Friday, February 25, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, February 24, 2022SOU EXTENSION 5 GRANTED
Thursday, February 17, 2022SOU EXTENSION 5 FILED
Thursday, February 24, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, February 17, 2022TEAS EXTENSION RECEIVED
Tuesday, August 24, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, August 20, 2021SOU EXTENSION 4 GRANTED
Friday, August 20, 2021SOU EXTENSION 4 FILED
Friday, August 20, 2021TEAS EXTENSION RECEIVED
Tuesday, February 2, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, January 29, 2021SOU EXTENSION 3 GRANTED
Friday, January 29, 2021SOU EXTENSION 3 FILED
Friday, January 29, 2021TEAS EXTENSION RECEIVED
Friday, August 21, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, August 19, 2020SOU EXTENSION 2 GRANTED
Wednesday, August 19, 2020SOU EXTENSION 2 FILED
Wednesday, August 19, 2020TEAS EXTENSION RECEIVED
Saturday, February 15, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, February 13, 2020SOU EXTENSION 1 GRANTED
Thursday, February 13, 2020SOU EXTENSION 1 FILED
Thursday, February 13, 2020TEAS EXTENSION RECEIVED
Tuesday, August 20, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 25, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 25, 2019PUBLISHED FOR OPPOSITION
Wednesday, June 5, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, May 17, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, May 17, 2019ASSIGNED TO EXAMINER
Wednesday, March 27, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, March 12, 2019NEW APPLICATION ENTERED IN TRAM